The final issue of The Patient for 2024 has been published (https://lnkd.in/gjBtR5Vk). In this issue: · Carolina Navas Cuerva, PhD, DVM et al. review the role of patient reported outcome instruments to measure treatment satisfaction across the life cycle of a drug therapy. They call for an increased measurement of treatment satisfaction in early and late phase drug development. · Eva-Lotta Hinzpeter et al. systematically review stated preference research in osteoporosis. They highlight significant heterogeneity and advocate for tailored treatment approaches · Benjamin M Craig et al. highlight a novel method for measuring health state preferences – Kaizen Tasks. They suggest a kaizen task is well suited for large descriptive systems or when targeting populations that are difficult to recruit · In a preference study of neurodevelopment follow-up care Pakhi Sharma et al. found there would be a significant uptake of care when families ideal preferences were accounted for. · Loria-Rebolledo et al. report that in a study of preferences for intrapartum care in rural areas women preferred to give birth in locations better able to manage complications. · Lidia Engel et al. found that the EQ-HWB needs further development in order to be fit for purpose in residential aged care settings · Alex Keenan et al. in a stated preference study found that patients with multiple sclerosis being treated with S1PR modulators preferred treatments with shorter immune system recovery time and fewer interactions with other drugs. · Thi Quynh Anh Ho et al. in a qualitative study regarding engagement of young people with web-based mental health interventions, found de-stigmatising campaigns are needed and that young people should be involved in the co-design of interventions · The final article in the issue contains the abstracts presented at the recent 15th meeting of the IAHPR. IAHPR Office.
Gahssan Mehmood
2mo
Thanks for sharing!
Pharmacoeconomics-centered Pharmacist living life #BeyondPrescriptions.
2moVery informative